| Data set | Procedure | What's in this data set | Panel | Sex | Age (weeks) | Year |
|---|---|---|---|---|---|---|
|
|
biomarker quantification | TMAO, choline, phosphocholine, glycerophosphocholine, betaine, carnitine. | both | 8-20wks | 2021 | |
|
|
body weight | Body weight | both | 8-20wks | 2021 | |
|
|
hormone quantification | Insulin, glucose:insulin ratio. | both | 8-20wks | 2021 | |
|
|
intake monitoring | Food intake; energy intake; protein, carbohydrate, fat intake. | both | 8-20wks | 2021 | |
|
|
lipid profile | Cholesterol, non-esterified fatty acids, triglyceride. | both | 8-20wks | 2021 | |
|
|
metabolic panel | Plasma enzymes, creatinine, glucose, urea, metabolic health score. | both | 8-20wks | 2021 | |
|
|
monitoring system | O2 consumption, CO2 production, RER, heat expenditure, activity. | both | 8-20wks | 2021 | |
|
|
MRI | Body composition (lean, fat, water). | both | 8-20wks | 2021 | |
|
|
body weight | Body weight | CC (50) | f | 17-72wks | 2017 |
|
|
MRI | Body composition (fat and lean mass and percent). | CC (50) | f | 17-72wks | 2017 |
|
|
treadmill endurance test | Maximal distance is recorded when mouse fails to run. | CC (50) | f | 17-72wks | 2017 |
|
|
body weight
with exercise |
Body weight before and after 2 weeks of exercise wheel availability. | CC (13) | f | 32-40wks | 2018 |
|
|
intake monitoring
with exercise |
Food intake during 2 weeks of exercise wheel availability. | CC (13) | f | 32-40wks | 2018 |
|
|
MRI
with exercise |
Body composition (fat and lean mass) before and after 2 weeks of exercise wheel availability. | CC (13) | f | 32-40wks | 2018 |
|
|
running wheel monitoring
with exercise |
Running wheel activity on days 11 and 12. | CC (13) | f | 32-40wks | 2018 |
|
|
body weight
with exercise |
Body weight before and after 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
|
MRI
with exercise |
Body composition (fat and lean mass) before and after 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
|
intake monitoring
with exercise |
Food and water intake, during 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
|
monitoring system
with exercise |
Locomotor activity, respiratory activity, body heat production, during 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
|
body weight | Body weight | CC (52) | m | 7-20wks | 2018 |
|
|
monitoring system | Social interaction and discrimination; activity, digging, grooming. | CC (52) | m | 7-20wks | 2018 |
|
|
organ weights | Brain weight. | CC (52) | m | 7-20wks | 2018 |
|
|
body weight | Body weight | CC (12) | m | 15-33wks | 2020 |
|
|
histopathology | Male reproductive histopathology. Percent normal, abnormal sperm. | CC (12) | m | 15-33wks | 2020 |
|
|
microscopy | Sperm motility | CC (12) | m | 15-33wks | 2020 |
|
|
organ weights | Male reproductive organ weights. Testes, seminal vesicles, epididymis + vas deferens. | CC (12) | m | 15-33wks | 2020 |
|
|
sperm count | Sperm count. Hemocytometer. | CC (12) | m | 15-33wks | 2020 |
|
|
microscopy | Sperm motility. | CC (12) | m | 15-33wks | 2020 |
|
|
genotyping | SNP profiling, 130,000+ genomic locations, 1-19,X,Y,MT. | CC w/par (77) | m | 2020 | |
|
|
genotyping | SNP profiling, 76,000+ genomic locations, 1-19,X,MT | CC w/par (77) | both | 2017 |